Rapamycin is a drug administered to patients who are undergoing organ transplant. Sirolium, as it is otherwise known, helps to prevent rejection of the new organ by patient’s bodies. The drug may also be administered for purposes of treating lung disease. It is a reliable coating in cases of coronary stents and also acts as a cancer treatment drug.
The case for Rapamycin
Rapamycin has been championed by Dr. Blagosklonny as a choice drug for patients undergoing organ transplant. While Calcineurin is another drug that can be used to counter the rejection of new organs by patient’s systems, it has demonstrated adverse effects to patients’ kidneys in the long run. Rapamycin on the other hand shows a much lower level of being toxic in the long run. Dr. Blagosklonny has also pointed out that the drug can be administered for the treatment of hemolytic-uremic syndrome. This disease is manifested in patients who have kidney failure, anemia and a low count of platelet. Rapamycin can also be administered as a treatment for Lymphangioleiomyomatosis. This is a disease that is more manifest in women who are able to conceive. Rapamycin can also be used to coat coronary stents. It is also a cancer treating drug. What the drug does, once it is administered, is to enhance the immune system and its response to the tumor in the body. It is therefore crucial in the limiting of cancer risk in patients who have experienced organ transplants. Rapamycin is also known to treat ‘tuberous sclerosis complex’, facial angiofibromas, Alzheimer’s disease, muscular dystrophy and ‘Systemic Lupus Erythematosus’. The drug is also fronted as a potion for increased longevity. The drug was used on mice with very encouraging results and therefore the theory of longevity.
All the above treatments are credited to Rapamycin. There are also other possible uses for the drug in treatment yet to be determined. Although research is still in its early stages, there is every indication of other treatment uses for the drug being realized.
Mikhail Blagosklonny and Oncology
Mikhail is a professor and an established researcher in the field of medicine and oncology. Mikhail’s focus is in cancer and aging. In his research Mikhail studies cancer and tries to find out why it is more common in people after a certain age. He believes there is a correlation and hence investigates the same. As a scientist and researcher, Mikhail is revered. He is also celebrated as an academic with the title of professor. The goal of Mikhail’s research is to discover or invent the treatment for cancer. He figures that treatment of the disease does not have to be as painful as it is at the moment given the chemotherapy and its excruciating effects. His purpose and vision has drawn many to his corner to aid in the research of a cure that does not rob people of their dignity and esteem. It is Mikhail’s belief that cancer treatment will in the future not be for the well to do alone, but for all individuals who are trapped in the disease irrespective of their financial standing.